Talzenna .1 mg/1

Talzenna .1 mg/1 capsules contain talazoparib, a medication used in cancer treatment. This oral medication is manufactured by Pfizer Laboratories and is available in a 30-capsule bottle.

Talzenna .1 mg/1 capsules are typically used in the treatment of certain types of cancer. Talazoparib is a PARP inhibitor, which may help in targeting cancer cells with specific genetic mutations. Patients often wonder, 'What is Talzenna used for?' and it is primarily indicated for conditions where PARP inhibition is beneficial.

Common effects of Talzenna .1 mg/1 capsules may include fatigue, nausea, and anemia. Some users may experience changes in taste or appetite. It is important to note that individual responses to the medication can vary.

Talzenna .1 mg/1 capsules should be handled with care. Store the medication at room temperature and keep it out of reach of children. Always follow the guidance of a healthcare provider regarding the use of this medication.

Talzenna .1 mg/1 capsules may interact with certain medications, including those that affect liver enzymes. It is advisable to discuss all current medications with a healthcare provider before starting talazoparib. Alcohol and other substances may also interact with this medication.